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Antisera were raised against peptides corresponding to the N-termini of capsid proteins VP1 and VP2 from the parvovirus
minute virus of mice. Epitopes in the 142-amino-acid VP1-specific region were not accessible in the great majority of newly
released viral particles, and sera directed against them failed to neutralize virus directly or deplete stocks of infectious
virions. However, brief exposure to temperatures of 45°C or more induced a conformational transition in a population of full
virions, but not in empty viral particles, in which VP1-specific sequences became externally accessible. In contrast, the VP2
N-terminus was antibody-accessible in all full, but not empty, particles without prior treatment. An electrophoretic mobility
shift assay, in which particles were heat-treated and/or preincubated with antibodies prior to electrophoresis, confirmed this
pattern of epitope accessibility, showing that the heat-induced conformational transition produces a retarded form of virion
that can be supershifted by incubation with VP1-specific sera. The proportion of virions undergoing transition increased with
temperature, but at all temperatures up to 70°C viral particles retained structure-specific antigenic determinants and
remained essentially intact, without shedding individual polypeptide species or subunits. However, despite the apparent
integrity of its protective coat, the genome became accessible to externally applied enzymes in an increasing proportion of
virions through this temperature range, suggesting that the conformational transitions that expose VP1 likely also allow
access to the genome. Heating particles to 80°C or above finally induced disassembly to polypeptide monomers. © 1999
Academic Press
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Parvoviruses have small (5 kb) single-stranded DNA
enomes encapsidated in approximately spherical, 280-
-diameter protein capsids in which 60 copies of the
oat protein are related by T 5 1 icosahedral symmetry
Agbandje et al., 1995). Virion proteins are encoded from
single gene, with alternative splicing allowing the syn-
hesis of two primary translation products, as described
n the legend to Fig. 1. VP2, a 64-kDa polypeptide com-
rising 587 amino acids, is the predominant species in
he empty capsid and newly released virion. VP1, an
3-kDa polypeptide present at approximately 10 copies
er particle, contains all of the VP2 sequence and, as
hown in Fig. 1, has an additional, basically charged,
42-amino-acid N-terminal extension, derived by initiat-
ng translation from an upstream methionine present
nly in a minor mRNA species (Cotmore and Tattersall,
987). A third capsid polypeptide, VP3, can be generated
n mature virions, but not in empty capsids, by proteolytic
leavage of VP2 molecules approximately 25 amino ac-
ds in from their N-termini. Although this same proteolytic
ite is present in VP1 molecules, it is not accessible to
1 To whom reprint requests should be addressed. Fax: (203) 688-
;340. E-mail: Peter.Tattersall@Yale.edu.
169roteolytic cleavage, suggesting that equivalent se-
uences in these peptides are disposed differently in the
article structure (Tattersall et al., 1977).
The three-dimensional structures of viral particles
rom canine parvovirus (CPV), feline parvovirus, and
inute virus of mice (MVM) have been determined to
tomic resolution by X-ray crystallography (Tsao et al.,
991; Agbandje et al., 1993; Wu and Rossmann, 1993; Xie
nd Chapman, 1996; Llamas-Saiz et al., 1997; Agbandje-
cKenna et al., 1998). For MVM, the atomic model iden-
ifies the position of 547 amino acids from the carboxy-
ermini of each capsid polypeptide chain, together with
pproximately 34% of the single-stranded DNA genome,
hich also displays icosahedral symmetry. However,
hile most of the protein sequence common to all three
apsid polypeptides can be distinguished in the crystal
tructure, this order is lost at residue 40 in VP2, so that
he locations of the N-terminal peptides of VP1 and VP2
181 and 39 amino acids, respectively) remain uncertain.
n the crystal structure, cylindrical projections encircled
y deep (15 Å) canyon-like depressions surround each of
he 12 five-fold symmetry axes, creating the second-most
rominent topological feature on the virion surface.
hese projections, which are created by juxtaposed anti-
arallel b-ribbons from each of the five-fold related
olypeptides, contain pores with a minimum diameter of
8 Å that penetrate through the capsid shell to the
0042-6822/99 $30.00
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170 COTMORE ET AL.article interior. VP2 residue 40 lies on the inside of the
apsid shell, at the base of these pores, and in mature
irions, but not in empty viral particles, the channels
ontain additional, weak, X-ray-dense material. Reanaly-
is of the CPV structure following refinement to 2.9 Å (Xie
nd Chapman, 1996) supports the idea that this weak
ensity represents peptide sequences from the N-
ermini of approximately 13% of the capsid polypeptides,
hich must therefore project to the particle exterior
hrough the pore, while the N-termini of the remaining
7% remain on the inside of the capsid. Subsequent
odeling of the MVM structure likewise indicated that
he first peptide that is differentiated from its five-fold
ymmetry related neighbors, a highly conserved glycine-
ich sequence (VP2 residue 28-GGSGGGGSGGG-38),
enoted by the dashed underline in Fig. 1, can be mod-
led into the weak density found along this channel,
hile residues 36-GGG-38 from nonexternalized capsid
roteins can be modeled extending into the interior of
he particle (Agbandje-McKenna et al., 1998). Since each
ore can accommodate only one N-terminal peptide, a
aximum of one in five of the N-termini can, theoretically,
e externalized, but it is not clear whether these peptides
elong to VP1 or VP2 molecules since the identified
equences are common to both. However, the observa-
ion that VP2 can be cleaved by externally applied trypsin
Tattersall et al., 1977) suggests that at least some of the
xternalized sequences belong to this species. In the
resent paper we use antisera directed against the
FIG. 1. Diagram of the N-termini of VP1 and VP2. The predicted amino
cid sequences of VP1 and VP2 are shown in single-letter code. VP1 is
ade from a minor viral mRNA species that is alternatively spliced, at
he junction indicated, so as to include the VP1 methionine start and a
hort (11 amino acid) exon contiguous with 131 amino acids of VP1-
pecific sequence and the whole of the VP2 sequence (only 58 resi-
ues shown). Most viral mRNAs are spliced to omit the VP1 start codon
nd the upstream exon, in which case translation starts at the VP2
-terminal methionine labeled 1. Regions predicted to be nuclear
ocalization signals by Tullis et al. (1993) are boxed. Sequences used to
aise anti-peptide antibodies are shown in boldface. The highly con-
erved sequence present in almost all parvoviral VP1-specific regions
s underlined. The polyglycine region modeled into the density running
hrough the five-fold pore is shaded. Indicated beneath the N-terminus
f VP2 is the (his)6-tag sequence engineered at the C-terminus of the E.
oli-expressed VP1-specific peptide described in the text.mino-terminal sequences of VP1 and VP2 to explore cheir accessibility in intact MVM virions and empty cap-
id particles.
Although parvovirus virions are known to be excep-
ionally rugged and resistant to inactivation (Berns et al.,
995), we know little about the strategies they employ to
raverse their host cell membranes and cytosol in order
o deliver their genomes to the nuclear replication ma-
hinery. Genetic analysis suggests that the VP1-specific
eptides of MVM, while not required for particle assem-
ly, genome encapsidation, or the release of virions from
heir initial host cell, are essential for some step in the
ubsequent infectious process, acting at an as yet un-
dentified point following receptor binding and virus in-
ernalization in subsequent host cells (Tullis et al., 1993;
axwell et al., 1995). The VP1-specific region contains
andidate karyopherin-a recognition sequences that
ould serve as nuclear localization signals and a se-
uence of about 40 amino acids (MVM VP1 residues
5–58) which likely fulfills some critical biological func-
ion since it is highly conserved throughout the Parvo-
iridae (Chen et al., 1986) with the sole exception of
leutian disease virus of mink (Bloom et al., 1988). In
ther viral families nuclear translocation of the incoming
enome is invariably mediated by one or more of the
irion polypeptides that possess the necessary cellular
ecognition signals and remain physically attached to the
enome following particle disassembly (Greber et al.,
994). Since the VP1-specific peptide contains such se-
uences and has been shown to mediate translocation
f newly synthesized VP1 molecules to the nucleus
Lombardo et al., 1997), it seems a likely candidate for
uch a trafficking vehicle. However, MVM virions are so
mall (280 Å diameter) that they could, theoretically, pass
hrough the nuclear pore without prior disassembly. It
as therefore of interest to ask whether VP1-specific
equences are exposed at the surface of newly released
irions, and, if not, to determine whether they can be
endered accessible in the intact particle or whether they
ecome accessible only following virion disassembly
nd separation of the individual polypeptides or sub-
nits.
RESULTS
he VP1-specific region is sequestered in the great
ajority of newly released full or empty MVM
articles
Newly released 35S-labeled full and empty MVM par-
icles were obtained from the medium of synchronized,
VM-infected A9 cells cultured in the presence of neur-
minidase and harvested approximately 30 h after re-
ease into S-phase. Since neuraminidase destroys the
9 receptor for MVM, these newly released particles had
either bound to cell surface receptors on the remaining
ost cells nor, subsequently, been taken up by those
ells. Such preparations are therefore significantly differ-
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171MVM VIRION STRUCTURAL TRANSITION EXPOSES VP1 AND VIRAL GENOMEnt from the great majority of parvovirus stocks de-
cribed in the literature that are routinely obtained from
nfected cell pellets after repeated rounds of infection
nd so contain mixed populations of particles including
ome that have yet to be released by their parental cell,
thers that have been released but have bound to the
urface receptors of new target cells, and others that
ave just penetrated new host cells. Since cell lysis is
till very limited in synchronized cells at this time in
nfection, full virions isolated under these conditions con-
ained predominantly VP1 and VP2 polypeptides, show-
ng little evidence of the proteolytic cleavage that later
enerates VP3 polypeptides from their VP2 precursors.
As expected, sera directed against the entire VP1-
pecific region of MVM expressed as a histidine-tagged
eptide in bacteria (anti-VP1) or against a synthetic pep-
ide corresponding to its N-terminal 19 amino acids (anti-
APPA) reacted exclusively with the capsid protein VP1
hen used to immunoprecipitate extensively denatured,
5S-labeled forms of the viral capsid (Fig. 2A, lanes 4 and
). Under the same conditions, a control serum directed
gainst the “allopeptide” sequence that is present in all
apsid polypeptides reacted with both VP1 and VP2 (Fig.
A, lane 6). In contrast, rabbit anti-capsid sera PN1 and
N2, raised by repeated immunization with small
mounts of intact capsids, reacted predominantly with
tructural determinants in the capsid, immunoprecipitat-
ng denatured capsid polypeptides poorly (Fig. 2A, lane
) but reacting efficiently with native capsids (Fig. 2A,
ane 7). A group of neutralizing monoclonal anti-capsid
ntibodies, illustrated here by MAb D10, similarly failed
o precipitate denatured polypeptides (Fig. 2A, lane 3).
he sera used in the following analyses can therefore be
rouped into two categories: (a) anti-peptide sera that
ecognize linear epitopes and (b) anti-structural determi-
ant sera that react with secondary, tertiary, or quater-
ary structures present only in the assembled particle.
When assayed under nondenaturing conditions, nei-
her full nor empty MVM particles could be effectively
mmunoprecipitated with anti-VP1 or anti-MAPPA sera
Figs. 2B and 2C, lanes 4 and 5), and while a significant
roportion of empty particles could be precipitated with
nti-allopeptide sera (28% of the total population in the
xperiment shown in Fig. 2B, lane 6), this peptide was
lso masked in the great majority of full particles (Fig. 2C,
ane 6). Thus, contrary to expectations, none of these
equences were accessible in most newly released
VM virions.
P1-specific epitopes become accessible in full
irions, but not in empty particles, following exposure
o heat
In many virus groups, virion structure has been shown
o be metastable, so that exposure to an external energy
ource, which experimentally often takes the form of aeat, induces them to undergo limited conformational
ransitions believed to mimic structural shifts seen in the
nfectious virion during the process of cell entry (Meyer
t al., 1992; Curry et al., 1996). To ask whether MVM
irions were similarly metastable, we heated virions and
mpty particles under physiological buffer conditions at
FIG. 2. Antibody specificity against denatured capsid proteins and
ntact particles. Fully denatured 35S-labeled capsid polypeptides (A)
eacted efficiently with antiallopeptide sera (lane 6) but were not im-
unoprecipitated with prebleed serum (lane 1) from a rabbit subse-
uently immunized with the entire VP1-specific sequence, while im-
une serum from the same rabbit specifically immunoprecipitated the
P1 polypeptide (lane 4), as did anti-MAPPA sera directed against the
-terminal 19 amino acids of this polypeptide (lane 5). In contrast, a
eutralizing anti-capsid monoclonal antibody, MAb D10, was unable to
eact with denatured particles (lane 3), and anti-capsid serum PN1
recipitated just trace amounts of VP2 from this mixture (lane 2), but
ould react efficiently with native empty particles (lane 7). Native
5S-labeled empty particles (B) or virions (C) were quantitatively pre-
ipitated with PN1 (B and C, lane 2), effectively removing all labeled
roteins from the unbound supernatant (B and C, lanes 1), but were not
recipitated with prebleed serum (B and C, lane 3) or anti-MAPPA (B
nd C, lane 5). Sera directed against the entire VP1-specific region
eacted with just a few particles of each type (B and C, lane 4), while
nti-allopeptide sera reacted poorly with virions (C, lane 6) but recog-
ized approximately 26% of empty particles (B, lane 6).range of different temperatures for 10 min before im-
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172 COTMORE ET AL.unoprecipitating them with anti-VP1 serum. This treat-
ent had little effect on the proportion of empty particles
hat could be precipitated (Fig. 3A), but heating to com-
arable temperatures produced a progressive increase
n the number of full virions that could subsequently be
recipitated with anti-VP1 (Fig. 3B). In the experiment
hown in Fig. 3B, 6% of virions were precipitated with
nti-VP1 following preincubation at room temperature or
7°C, 14% were precipitated with anti-VP1 after heating
o 45°C, 29% after heating to 52°C, 55% after heating to
0°C, and 67% after heating to 70°C. Similar values were
btained in separate studies, although the exact propor-
ions varied somewhat from experiment to experiment.
While in this experiment samples were heated for 10
in, time course studies carried out at several temper-
tures in this range suggested that the transition rou-
inely occurred within 3 min, so that the proportion of
FIG. 3. Effect of heating particles on their reactivity with anti-VP1 or
Ab D10. Native 35S-labeled empty particle (A) and virions (B) were
ncubated for 10 min at the various temperatures indicated above Panel
and then immunoprecipitated with antisera to the VP1-specific region
lanes 1 through 6). Samples preincubated at room temperature (RT)
nd then quantitatively immunoprecipitated with PN1 anti-whole-cap-
id serum are shown in lanes 7. In C, native 35S-labeled virions were
reincubated for 10 min at 20°C (lane 1), 60°C (lane 2), 70°C (lane 3),
nd 80°C (lane 4), before being immunoprecipitated with the neutral-
zing monoclonal antibody D10. Samples preincubated at 80°C could
till be quantitatively precipitated with anti-allopeptide sera (lane 5).articles affected was determined predominantly by the iemperature, rather than the duration, of each incubation
data not shown). Throughout this initial range of tem-
eratures, up to 70°C, VP2 was coprecipitated in normal
apsid proportions with the VP1 polypeptides, suggest-
ng that the particles remained essentially intact.
Preincubation at temperatures up to 70°C had little
ffect upon the reactivity of MVM particles with the neu-
ralizing monoclonal antibody D10 (Fig. 3C) or with poly-
lonal anti-capsid serum PN1 (data not shown), indicat-
ng that despite the conformational changes that led to
P1 exposure, a variety of structural epitopes remained
rdered. However, at higher temperatures such reactivity
as rapidly lost. This was most apparent in the example
hown in Fig. 3C, where all reactivity with the monoclo-
al antibody D10 was lost following heating to 80°C,
ven though the remaining peptides could be quantita-
ively precipitated with anti-allopeptide serum (Fig. 3C,
ompare lanes 4 and 5). Reactivity with polyclonal serum
N1 was lost more gradually, with approximately 20%
emaining after treatment at 80°C, but rapidly diminish-
ng thereafter (data not shown). Thus reactivity with an-
ibodies directed against structural determinants is pre-
erved up to 70°C but is lost at higher temperatures,
ndicating that, above this temperature, the particle un-
ergoes a major structural reorganization.
era directed against the N-termini of VP1 have little
ffect on viral infectivity in culture
Since VP1-specific sera failed to react with the great
ajority of newly released virions, we might not expect
hem to neutralize viral infectivity. However, the particle
o infectivity ratio of MVMp when used to infect A9 cells
n culture is approximately 300:1 (Tattersall, 1972), and
hus it remained possible that the small proportion of
on-heat-treated full particles that appeared to precipi-
ate with anti-VP1 sera (;7% in Fig. 3B) could represent
highly infectious subset, accounting for most of the
nfectivity in the viral stock. To explore this possibility we
irst assessed the ability of each serum to neutralize
VM infections in cell culture using standard laboratory
tocks of virus. Under assay conditions described under
aterials and Methods, anti-capsid sera PN1 and PN2
eutralized infection totally at all dilutions from 1021 to
026 and had a partial effect at 1027, while anti-VP1
erum, anti-MAPPA serum, and prebleed samples from
he same rabbits failed to have any influence on virus
nfectivity at all dilutions tested (from 1021 to 10210).
These results also indicate that particles with VP1-
pecific residues exposed do not account for a major
roportion of the infectious virus in standard laboratory
tocks or that antibodies directed against these epitopes
re not neutralizing. We addressed this question using
he more extensively characterized, newly released viral
reparations described above. Immunodepletion exper-ments were carried out in which these stocks were first
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173MVM VIRION STRUCTURAL TRANSITION EXPOSES VP1 AND VIRAL GENOMEleared of all subpopulations reacting with a particular
ntiserum, by adding that serum plus an immunoadsor-
ant, and the titer of the remaining virus was then com-
ared to samples similarly cleared with prebleed serum.
esults from such experiments, shown in Table 1, indi-
ate that the small proportion of virions that have VP1-
pecific epitopes exposed at their surface do not consti-
ute a highly infectious subpopulation of virus and that
FIG. 4. N-terminal sequences of VP2 are exposed at the surface of all
irions, but on few empty particles. (A) Native 35S-labeled virions (lanes
–3) and empty particles (lanes 4–6) were quantitatively immunopre-
ipitated with PN1 (lanes 1 and 4). Prebleed serum (from a rabbit
ubsequently immunized with the MSDGT oligopeptide corresponding
o the N-terminal 25 amino acids of VP2) failed to react with either type
f particle (lanes 2 and 5), but immune serum from the same rabbit
recipitated virions efficiently (lane 3), while failing to react with most
mpty particles (lane 6). (B) Native 35S-labeled virions were preincu-
ated for 10 min at 37 or 60°C before being quantitatively immunopre-
ipitated with sera directed against the N-terminus of VP2 (lanes 1 and
, respectively). Unbound material from such precipitations did not
ontain any labeled species that could subsequently be precipitated
ith PN1 (lanes 3 and 4, respectively). Equivalent unbound samples
acked any material that reacted with sera directed against the VP1-
pecific region (lanes 5 and 6, respectively). The proportion of native
5S-labeled virions that could be precipitated directly with anti-VP1-
pecific sera following preincubation at 60°C is shown in lane 7. Native
5S-labeled empty particles reacted poorly with sera directed against
he N-terminus of VP2 following preincubation at 37 or 60°C (lanes 8
TABLE 1
Immunodepletion with Anti-VP1-Specific Sera
Does Not Reduce Virus Titers
Antibody used
Remaining titer (PFU/ml)
Experiment 1 Experiment 2
one 23107 3.53107
onimmune serum 8.83106 2.93107
nti-VP1 9.53106 3.43107
nti-MAPPA ND 3.53107
nti-capsid PN1 ,2.53104 ,2.53104
Note. ND, not determined.snd 9, respectively).articles in which these determinants remain seques-
ered are infectious.
P2 N-termini are exposed in all full MVM virions, but
re sequestered in empty particles
Rabbit anti-MSDGT, raised against a synthetic peptide
orresponding to the N-terminal 25 residues of VP2,
mmunoprecipitated all full MVM virions, reacting as ef-
iciently as the rabbit anti-whole-capsid serum PN1,
hen analyzed under nondenaturing conditions (Fig. 4A,
ompare lanes 1 and 3). Under the same conditions,
owever, this serum immunoprecipitated empty viral par-
icles with very low efficiency (Fig. 4A, lane 6), compared
o PN1 (Fig. 4A, lane 4).
Exposure to 37 or 60°C for 10 min had little effect on
irion reactivity with anti-MSDGT (Fig. 4B, lanes 1 and 2).
mmunoprecipitation with anti-MSDGT removed essen-
ially all of the full particles in the first round, so that none
emained in the unbound material to be scavenged ei-
her with PN1 (Fig. 4B, lanes 3 and 4) or, in parallel
amples, with anti-VP1 (Fig. 4B, lanes 5 and 6). For
omparison, the increased proportion of full particles
hat became susceptible to precipitation with anti-VP1
ollowing heat treatment at 60°C is shown in Fig. 4B, lane
. Identical treatment of empty capsids at 37 or 60°C had
o effect on their nonreactivity with anti-MSDGT (Fig. 4B,
anes 8 and 9). Thus, unlike the VP1 N-terminus, N-
ermini of VP2 are available at the surface of all newly
eleased MVM virions without any temperature-induced
ransition(s), but neither VP1 nor VP2 N-terminal se-
uences are accessible on the surface of empty capsids
r can be made so by heating. This suggests that it is the
resence of the viral DNA inside virions that provides the
orce underlying both the constitutive protrusion of VP2
-termini and the heat-triggered expulsion of the VP1-
TABLE 2
Heat Inactivation of Viral Infectivity Correlates with the Proportion
of Virions in Which VP1-Specific Sequences Are Exposed
Pretreatment
% VP2 precipitated
with anti-VP1a
Infectivity
Remaining PFU Inactivation
RT 5.0% 7.03106 —
37°C 3.9% 5.03106 29%
45°C 8.6% 5.83106 17%
52°C 30% 4.13106 41%
60°C 73% 2.53106 64%
70°C 74% 1.43106 80%
80°C 23%a 1.73105 98%
90°C 13%a ,2.53104 .99.6%
a Amount of VP1 precipitated by anti-VP1 was between 94 and 97% in
ach case.pecific region.
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174 COTMORE ET AL.iral infectivity titers drop as VP1-specific sequences
ecome exposed
To assess whether or not virions that had undergone
eat-induced conformational shifts were infectious, we
arried out the experiment shown in Table 2, in which
5S-labeled virions were heated to various temperatures
or 10 min in tissue culture medium containing 10% fetal
ovine serum before being split into two aliquots to be
sed for immunoprecipitation with anti-VP1 and for infec-
ivity assays. Despite the inherent variability of parvoviral
nfectivity assays, it is apparent from Table 2 that heating
t temperatures up to 52°C had little effect on the infec-
ivity of this virus stock. However, upon heating at higher
emperatures, up to 70°C, the infectious titer dropped
pproximately in proportion to the increase in virions
ith exposed VP1-specific sequences. This suggests
hat virions that have exposed VP1 N-termini are proba-
ly no longer infectious, at least when applied to the
utside of the cell.
eated virions with VP1 epitopes exposed are
therwise intact
Since immunoprecipitation is a somewhat protracted
rocedure, we wished to use a more direct and rapid
echnique to monitor particle structure and antibody in-
eractions. To this end, we developed an electrophoretic
obility shift assay (EMSA), using 35S-labeled particles.
ven though crystallographic studies show that intact
irions and empty viral particles have essentially the
ame size and surface structure (Llamas-Saiz et al.,
997; Agbandje-McKenna et al., 1998), virions migrated
ubstantially faster when electrophoresed through low-
ercentage agarose gels (Fig. 5A, compare lanes 1 and
). This likely reflects a difference in net surface charge
etween the two structures, but precise measurements
f this were not attempted. Despite this difference, when
ither type of particle was preincubated with antibodies
irected against surface epitopes, its migration was ef-
ectively retarded, and the extent to which it was retarded
ppeared to reflect the number of antibody molecules
ound. This is shown for empty particles in Fig. 5A,
here tissue-culture medium from a control hybridoma
upernatant failed to influence particle mobility at a di-
ution of 1:25 (Fig. 5A, lane 3), while supernatant from the
nti-capsid hybridoma MAb D10 shifted all particles to
he top of the gel at dilutions of 1:25, 1:50, and 1:100 (Fig.
A, lanes 4–6, respectively). This monoclonal antibody is
otentially able to bind one antigen-combining site to
ach of the 60 asymmetric units in the capsid and only at
ilutions of 1:200 and 1:400 allowed some particles to
nter the gel, migrating as a new band that was still
etarded relative to the input particles (Fig. 5A, lanes 7
nd 8). The stoichiometry of antibodies to particles in this
and has not been determined, but the high dilutionequired to obtain this shift suggests that relatively few cntibodies were bound to each particle that entered the
el and that this technique might be useful for isolating
pecific virus:antibody complexes.
Both the empty particles and the full virions used in
hese studies were made up predominantly of VP2 mol-
cules (Fig. 5B, lanes 1 and 2), but when the latter were
xposed to trypsin in vitro, most of the VP2 chains were
FIG. 5. Electrophoretic mobility shift assay analysis. (A) Native 35S-
abeled virions (lane 1) and empty viral particles (lanes 2–8) were
lectrophoresed through native 1% agarose gels before (lanes 1 and 2)
nd after incubation for 30 min with a 1:25 dilution of control tissue
ulture medium (lane 3) or the following dilutions of medium from the
nti-capsid hybridoma MAb D10: 1:25 (lane 4), 1:50 (lane 5), 1:100 (lane
), 1:200 (lane 7), or 1:400 (lane 8). E, empty particles; V, virions; C,
article:antibody complexes. (B) Discontinuous SDS–polyacrylamide
el showing 35S-labeled capsid proteins from untreated empty particles
lane 1) and virions before (lane 2) and after (lane 3) treatment with
rypsin, as described under Materials and Methods. (C) Untreated
ative 35S-labeled empty particles (lane 1) and virions before (lane 2)
nd after (lane 3) treatment with trypsin were electrophoresed through
ative 1% agarose gels. Undigested 35S-labeled virions are also shown
ollowing 10 min of preincubation at 37°C (lane 4), 45°C (lane 5), 65°C
lane 6), and 85°C (lane 7). E, empty particles; V, virions; VP, polypeptide
ubunits. (D) Untreated native 35S-labeled empty particles (lane 1) and
irions (lanes 2–11) were electrophoresed through native 1% agarose
els before (lane 2) and after incubation with antisera directed against
he following determinants: VP1-specific region (1:100 dilution, lane 3);
rebleed serum from a rabbit subsequently immunized with the N-
erminal peptide of VP2 (1:100 dilution, lane 4); immune serum from the
ame rabbit (1:100 dilution, lane 5; 1:50 dilution, lane 6); 1:100 dilution
f culture medium from MAb D10 (lane 7). Native 35S-labeled virions
ere also preincubated for 10 min at 60°C and electrophoresed before
lane 8) or after incubation with the following sera: prebleed serum from
rabbit subsequently immunized with the VP1-specific region (1:100
ilution, lane 9); immune serum from the same rabbit (1:100 dilution,
ane 10); anti-capsid MAb D10 (1:100 dilution, lane 11). E, empty parti-
les; V, virions.leaved to VP3-like polypeptides by removal of the ex-
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175MVM VIRION STRUCTURAL TRANSITION EXPOSES VP1 AND VIRAL GENOMEosed N-terminal peptide (Fig. 5B, lane 3). Attempts to
leave the few remaining VP2 molecules by prolonged
xposure to trypsin have not been successful, suggest-
ng that the residual N-termini are not normally exposed
t the virion surface (Tattersall et al., 1977). When the
lectrophoretic mobilities of such populations were com-
ared (Fig. 5C, lanes 1–3), it became apparent that re-
oving the exposed N-termini of VP2 significantly re-
uced the migration rate of virions, so that they now
omigrated with empty particles (Fig. 5C, compare lanes
and 3).
The mobility of full particles could also be influenced,
lbeit less dramatically, by heating. The effects of heating
ull particles to 37, 45, 65, and 85°C are shown in Fig. 5C,
anes 4–7, respectively. Each particle population mi-
rated as a rather broad band, which presumably re-
lects charge heterogeneity within it, since DNA frag-
ents electrophoresed in the same gel migrated as
harp bands (data not shown). After incubation at 60°C,
owever, a new and quite distinctly lower mobility form of
he virion was apparent (Fig. 5C, lane 6). This form likely
epresents particles that have one or more of their highly
asic VP1-specific peptides exposed at the particle sur-
ace as a result of the heat-induced conformational shift
see below). After being heated to 85°C, labeled proteins
igrated much more rapidly than intact particles, sug-
esting that they had fallen apart into subunits or free
olypeptides (Fig. 5C, lane 7).
We next used this EMSA approach to explore further
he effects of sera directed against the N-termini of VP1
nd VP2 on virion populations before and after heat
reatment. While the migration of full particles was not
nfluenced by incubation with anti-VP1-specific serum
Fig. 5D, lane 3) or with preimmune serum from a rabbit
ubsequently immunized with the VP2 N-terminal MS-
GT peptide (Fig. 5D, lane 4), particle migration was
omewhat retarded by incubation with anti-MSDGT im-
une serum (Fig. 5D, lane 5). However, the antibody:
article complexes generated with this serum entered
he gel and migrated only slightly slower than input
irions. By analogy with the results shown in Fig. 5A,
herefore, it seems likely that substantially fewer than 60
ntibody molecules were bound to each virion in this
ase. That this was a function of capsid structure rather
han antibody concentration was indicated by the fact
hat adding twice as much serum had little additional
ffect on the distribution of retarded particles (Fig. 5D,
ane 6). In contrast, most virions failed to enter the gel
fter incubation with a 1:100 dilution of the anti-capsid
onoclonal antibody (Fig. 5D, lane 7), suggesting that in
his case many more antibodies were bound to each
article.
After virions were heated to 60°C, a subpopulation of
articles that had undergone a conformational transition
nd thus migrated more slowly than the rest of the input
as once again apparent (Fig. 5D, lane 8), and while wncubation with a preimmune serum had no influence on
he mobility of either particle type in this heated sample
Fig. 5D, lane 9), incubation with anti-VP1-specific im-
une serum caused the new, heat-induced species to
e further retarded (Fig. 5D, lane 10) while having no
nfluence on the mobility of the nonmodified form. Thus,
eating induces a conformational shift in virion structure
hat reduces its electrophoretic mobility and causes VP1-
pecific sequences to become accessible at the particle
urface. Since the retarded band generated with anti-
P1-specific serum migrated well within the gel, we
resume that relatively few antibodies were bound in
ach complex. In contrast, antibodies directed against
he intact capsid shifted essentially the entire particle
opulation to the gel interface even after heat treatment
Fig. 5D, lane 11).
articles remain intact when heated to 70°C, but
apidly dissociate into monomeric polypeptides at
igher temperatures
To assess the integrity of the particle following heating
FIG. 6. Gradient polyacrylamide gel analysis of virion structural
ntegrity following heat treatment. Untreated 35S-labeled virions, incu-
ated with 1% SDS at 37°C for 30 min before electrophoresis through
radient polyacrylamide gels in the presence of 0.1% SDS, migrated as
arge structures near the top of the gradient (lane 1). Equivalent sam-
les were exposed to similar treatment after preincubation for 10 min
t the following temperatures under physiological buffer conditions:
7°C (lane 2), 60°C (lane 3), 70°C (lane 4), and 85°C (lane 5). Samples
oiled in 1% SDS for 5 min prior to electrophoresis are shown in lane
. Apparent MWs are indicated along the left margin, and the theoret-
cal positions of VP1 pentamers (83 kDa 35), VP2 pentamers (64 kDa
5), and VP2 trimers (64 kDa 33) are indicated on the right.e exposed virions to a range of different temperatures
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176 COTMORE ET AL.nder physiological buffer conditions, bound SDS to
hem at 37°C, and then electrophoresed them through
radient polyacrylamide gels without further heating. If
ative particles were exposed to this treatment (Fig. 6,
ane 1), they migrated as large structures near the top of
he gradient, well above the highest molecular weight
arker (thyroglobulin, MW 600 kDa), but if denatured by
oiling in SDS sample buffer prior to electrophoresis,
hey dissociated into monomeric VP1 and VP2 polypep-
ides (Fig. 6, lane 6). Experimental samples that had been
xposed to temperatures of 37, 60, or 70°C for 10 min,
rior to the addition of SDS, comigrated near the top of
he gel with the native virions, showing no evidence of
isintegration into intermediate trimer or pentamer sub-
nits or any evidence that VP1 was preferentially re-
eased from the particles by this treatment (Fig. 6, lanes
–4). However, when heated to 85°C particles dissoci-
ted totally into monomeric VP1 and VP2 polypeptides
Fig. 6, lane 5) that comigrated with viral polypeptides
eleased from the virion by boiling in sample buffer (Fig.
, lane 6). This confirms the previous observations that at
emperatures up to 70°C virion polypeptides remain pre-
ominantly associated as intact particles, while at higher
emperatures both structural epitopes and the ability to
oprecipitate VP2 with anti-VP1 are rapidly lost as the
article disintegrates into its component polypeptides.
iral DNA becomes progressively exposed at
emperatures above 52°C
To determine whether viral DNA was still protected
rom the external environment in particles that had un-
ergone the heat-induced conformational shift, we mixed
irions that had 35S-labeled capsid proteins with others
hat had 32P-labeled DNA and exposed samples of the
ixture to a variety of temperatures. Individual samples
ere then divided into three equal aliquots, one of which
as immunoprecipitated with anti-VP1 serum, a second
igested with P1 nuclease, while the remaining aliquot
as incubated with Sequenase and unlabeled de-
xynucleotides in order to replicate any exposed viral
NA. The last assay, in particular, measures the avail-
bility of the genomic 39 end, which, in its hairpin con-
iguration, will prime synthesis of a DNA strand comple-
entary to packaged DNA, creating full-length duplex
onomer forms of the viral genome.
Most, if not all, purified virion preparations appear to
e contaminated with some unpackaged genomic DNA,
resumably released by particles that become dena-
ured during purification or during subsequent dilution
sing plastic tips and tubes in this experiment (see
aterials and Methods). However, the proportion of such
ree DNA in the virions assayed here was quite low (Fig.
B, compare lanes 1 and 2, and Fig. 7C, compare lanes
and 3). After heating to 37 or 45°C there was little, ifny, increase in the susceptibility of viral DNA to P1 tuclease or Sequenase, suggesting that the genome
emained essentially sequestered. However, at higher
emperatures the genome became increasingly exposed
o these enzymes, so that after being heated to 70°C
ost of the viral DNA was susceptible to P1 nuclease,
lthough a somewhat lower proportion served as a poly-
erase substrate. Throughout this temperature range,
P1:VP2 ratios in the anti-VP1 precipitates suggested
hat particles had not disintegrated, but rather that the
onformational shifts induced by heating led to exposure
f both the viral genome and, as previously demon-
trated, the VP1-specific sequences. This indicates that,
nergetically speaking, it is significantly easier to expose
he MVM genome in the context of its intact capsid shell
han it is to induce that capsid to dissociate into polypep-
FIG. 7. VP1 and the viral genome become concomitantly accessible
t the virion surface upon heating. Virions with 35S-labeled capsid
roteins were mixed with virions labeled with 32P in their DNA. Aliquots
f this mixture were analyzed by gel electrophoresis as described
nder Materials and Methods, after exposure to the indicated temper-
tures, and subsequently immunoprecipitated with sera against the
P1-specific region (A), digested with nuclease P1 (B), or incubated
ith Sequenase in the presence of unlabeled dNTPs (C). For compar-
son, untreated aliquots were also precipitated with PN1 (A, lane 10) or
ncubated without the modifying enzyme before or after exposure to
eat (B, lanes 1 and 9; C, lanes 1, 2, and 9).ide subunits.
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177MVM VIRION STRUCTURAL TRANSITION EXPOSES VP1 AND VIRAL GENOMEDISCUSSION
Since X-ray crystallographic analysis has not provided
recise structural information concerning the disposition
f the N-terminal regions of VP1 and VP2 within the MVM
article, we have used peptide-specific antibodies to
how that while the N-termini of some VP2 molecules are
xposed at the surface of the newly released virion, the
ntire N-terminal 142-amino-acid peptide specific to VP1
olecules is sequestered within it. This observation is
omewhat unexpected because the analogous 227-
mino-acid, VP1-specific peptide from parvovirus B19
as been shown to be surface accessible both in recom-
inant capsids, expressed in insect cells from baculovi-
us vectors, and in authentic serum-derived virus, where
ntisera directed against VP1 sequences could be used
o neutralize viral infectivity in vitro (Rosenfeld et al.,
992; Anderson et al., 1995). However, MVM and B19
elong to different genera in the subfamily Parvovirinae
nd are genetically and structurally quite different from
ach other (Berns et al., 1995). While, to date, the X-ray
tructure of B19 has been determined only for recombi-
ant empty particles at low resolution (8 Å), their surface
opology does appear quite distinct. In particular, the
ive-fold cylinders, which in MVM, CPV, and FPV virions
ppear to be hollow and modulate surface exposure of
he VP N-termini, are closed in B19 (Agbandje et al.,
994). Whether this apparent structural difference be-
ween the genera translates into different mechanisms of
ell entry, intracellular trafficking, or uncoating of the
enome remains to be explored.
Our data suggest that the glycine-rich sequence mod-
led into the cylindrical pore at the five-fold symmetry
xis of the MVM particle is derived exclusively from VP2
olecules and that similar sequences from VP1 remain
nside the capsid shell in close proximity to the DNA. In
ccord with the crystallographic data, neither of these
-terminal sequences is exposed at the surface of empty
iral particles. In the crystal structure the pore is rela-
ively narrow (,8 Å), so that it can accommodate only a
ingle, unstructured peptide chain composed of amino
cids that lack bulky side groups, such as the glycine/
erine-rich sequence found between VP2 residues 28
nd 38 (GGSGGGGSGGG) in MVM. As a result, a maxi-
um of 12 VP2 N-termini would be expected to project
rom the particle surface at any one time.
Our electrophoretic mobility shift data support the idea
hat exposure of VP2 N-termini is limited, since immune
omplexes generated using anti-VP2 sera have much
igher mobilities than similar complexes generated us-
ng antibodies that potentially recognize 60 epitopes on
he particle surface. Similarly, Cortes et al. (1993) were
nable to decorate virions with gold particles tagged to
onoclonal antibodies directed against the N-terminus
f CPV VP2 molecules, presumably because there were
elatively few epitopes available to label, even though these antibodies were able to neutralize viral infectivity
n vitro. However, when incubated with trypsin at 37°C,
ost of the VP2 molecules in newly released MVM
irions can be cleaved at a position immediately N-
erminal to the glycine-rich tract [see Fig. 5B and Tatter-
all et al. (1977)]. This suggests that even at 37°C there
ust be considerable flexibility in the capsid structure,
llowing the pores to open and accommodate multiple
olypeptide chains at one time or, at least, to allow the
ulky side groups of N-terminal peptides from succes-
ive VP2 molecules to be threaded through the pore after
he first molecule has been cleaved and its glycine chain
etracted. Previously we have shown that in newly re-
eased MVM virions 24 nucleotides from the 59 end of the
ingle-stranded DNA genome also remain exposed to
he external environment at the particle surface (Cotmore
nd Tattersall, 1989), and although we do not know
xactly where this chain penetrates the capsid shell,
lexibility around the five-fold pores would definitely be
equired to accommodate such a large structure by this
oute. However, the cylindrical projections that surround
hese pores appear to have few restraints that would
eriously impede their opening, and although energy
ould be required to break existing interchain bonds,
tudies with poliovirus suggest that at 37°C the capsids
f nonenveloped viruses can be substantially more flex-
ble than their crystal structures indicate (Li et al., 1994).
hus, while the three-fold axes of MVM are spanned by
omplex, interwoven polypeptide chains, the five-fold
ylinders are composed of antiparallel b-ribbons from
ive different polypeptide chains that do not interdigitate
round the upper part of the channel. Intersubunit con-
acts in the cylinders might, therefore, be broken and the
ndividual peptide loops move outward into the space
ade available by the surrounding canyon, to facilitate
he egress of larger structures.
It is tempting to speculate that heating particles to
5°C or above might induce even more extreme flexing
f the five-fold cylinders, resulting in the conformational
ransitions described in this paper that render VP1-spe-
ific sequences surface-accessible and ultimately allow
gress of the genome. Like many viruses, MVM must
ssemble a rugged protective virion in its parental host
ell, which can protect its genome from the external
nvironment and conditions encountered in the entry
ortals of its subsequent host cell, but which can then
raffic its genome to the nucleus and open or disassem-
le in such a way as to render the genome accessible for
eplication by host enzymes. To this end, mature virions
rom many viral groups are known to be metastable,
ndergoing conformational transitions required for suc-
essive steps in the infectious process in response to
pecific stimuli encountered during entry [reviewed in
reber et al. (1994)]. In some cases such transitions can
lso be induced experimentally by exposure to elevatedemperatures (Curry et al., 1996), and it was our hope that
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178 COTMORE ET AL.e would be able to recapitulate the heat-induced MVM
onformational transitions described here using experi-
ental conditions that the virus would be likely to en-
ounter during the early stages of entry. Thus, for exam-
le, entry of both CPV and MVM can be blocked by drugs
hat prevent lowering of the endosomal pH (Basak and
urner, 1992; J. Gerlach and P. Tattersall, unpublished
esults), suggesting that these viruses pass through an
bligate acidic environment during entry. However, ex-
osure to acidic conditions alone (pH 4.5–6.0 for 30 min)
ailed to render the N-termini of VP1 surface accessible
data not shown). Likewise, exposure to the protease
rypsin effectively cleaved most VP2 molecules to VP3,
s occurs during entry, but failed to induce exposure of
P1-specific sequences. Moreover, exposure to a buffer
onsisting of 1 mM EGTA, 10 mM DTT, 50 mM Tris–HCl,
H 8.0, at 37°C for 1 h followed by addition of KCl to 850
M and continued incubation for 30 min, recreating the
onditions of calcium depletion and ionic shock used by
ean and colleagues to bring about the release of VP1
olecules from SV40 particles (Dean et al., 1995), had no
ffect on exposure of the MVM VP1 N-terminal epitopes
data not shown). It should also be noted that incubation
n 1% SDS at 37°C for 30 min failed to render these
equences accessible (data not shown), suggesting that
more specific stimulus is required to induce the MVM
onformational shifts we describe.
It is thus of interest that when intact full MVM virions
re incubated in the type of HeLa cell-free S100 extracts
e routinely use to study viral DNA replication in vitro
Christensen et al., 1997), a significant proportion of the
articles (;30%) undergo a structural alteration that ren-
ers their genomes accessible to the cellular replication
achinery (Cotmore et al., 1998). This transition leaves
he particle essentially intact, as evidenced by the fact
hat they can be immunoprecipitated with various struc-
ure-specific antibodies. During the process, the VP1-
pecific sequences are exposed and the newly repli-
ated genome remains tightly associated with the now
mpty particle. Although this would represent a novel
echanism, disassembly of alphaviruses is known to be
ediated by a specific cellular uncoating factor(s) asso-
iated with ribosomes (Wengler et al., 1996). Previsani et
l. (1997) have previously reported that extracts of EL4
ymphocytes contain a factor that can destabilize the
irions of MVMi, an MVM serotype that replicates pro-
uctively in murine lymphocytes, but not those of MVMp,
he fibrotropic virus used in the studies reported here.
xactly which component of the replication extract in-
uces this transition remains uncertain, but we are op-
imistic that the electrophoretic mobility shift assay de-
cribed here will facilitate identification of the modulat-
ng factors and the conditions required for their
peration. wMATERIALS AND METHODS
ells, viruses, and isotopic-labeling protocols
The prototype strain of MVM (MVMp) was grown in the
urine L-cell derivative A9 ouabr11 as previously de-
cribed (Tattersall and Bratton, 1983). Cells were syn-
hronized using a double-block procedure described
lsewhere (Cotmore and Tattersall, 1987). Briefly, cells
ere allowed to accumulate in G0 by withholding isoleu-
ine for 48 h and then were released from the isoleucine
lock while simultaneously being exposed to 10 mg/ml
phidicolin. MVM virions (10 PFU/cell) were added to the
ells along with the polymerase inhibitor and were able
o penetrate cells and deliver their genomes to the nuclei
n the 20 h before the inhibitor was finally removed. All
imes of infection referred to here initiate at the point
hen the aphidicolin was finally removed and the cells
ecame free to enter the S-phase of the cell cycle.
Infected cells were labeled with Trans 35S-label (ICN
adiochemicals, Irvine, CA) at 0.2 mCi/ml in Dulbecco’s
odified Eagle’s minimal medium containing 1/100 of the
ormal concentration of unlabeled methionine and cys-
eine and 5% dialyzed fetal calf serum or with
32P]orthophosphate at 0.5 mCi/ml in medium containing
/10 the normal concentration of unlabeled phosphate
nd 5% dialyzed fetal calf serum. Label was added 6 h
fter the cells were released into S-phase and removed
h later (t 5 113), to be replaced with medium contain-
ng Clostridium perfringens neuraminidase (Sigma
hemical Co., St. Louis, MO) at 0.1 mg/ml. Neuramini-
ase destroys the A9 cell surface receptor used by MVM
Cotmore and Tattersall, 1989) and thus prevents newly
eleased virus from adhering to or reentering host cells.
ewly released virus was harvested by collecting the
ulture medium 12 h later (t 5 25) and cleared of cellular
ebris by centrifugation at 15,000 g for 30 min at 4°C.
leared supernatant was layered, in 5.5-ml amounts,
nto 1 ml 60% sucrose on top of 4 ml CsCl (density 1.40),
oth in TE8.7 (0.5 mM EDTA, 50 mM Tris–HCl, pH 8.7)
ontaining 1% fetal bovine serum, and centrifuged at
0,000 rpm for 25 h at 4°C in a Beckman SW41 rotor.
ractions were collected by aspiration from the bottom of
he tube and analyzed for virus by hemagglutination
ssay, radiolabel profile, and gel electrophoresis. Peak
ractions of full virions and empty capsids were pooled
eparately and dialyzed against three changes of 1000
ol of TE8.7 in the cold.
nfectivity and virus neutralization assays
MVM stocks were assayed for infectivity and antibody-
ediated neutralization by plaque assay on 324K mono-
ayers as described elsewhere (Tattersall and Bratton,
983). For the immunodepletion experiments, samples
ere incubated with test and control sera as described
elow for immunoprecipitation, and residual viral titers
ere determined by plaque assay.
C
t
a
s
h
e
w
c
p
m
n
i
i
p
t
o
i
s
t
J
c
b
t
w
e
o
e
m
e
i
b
k
f
p
w
k
p
o
i
w
r
w
a
s
w
p
w
p
a
(
t
t
e
p
A
p
s
K
s
V
N
A
2
a
a
n
[
t
T
t
c
M
r
c
s
C
A
t
p
A
r
i
t
G
p
p
1
H
r
t
e
t
a
b
a
T
1
179MVM VIRION STRUCTURAL TRANSITION EXPOSES VP1 AND VIRAL GENOMEonstruction and bacterial expression of a histidine-
agged form of the VP1-specific region
A DNA sequence encoding the N-terminal 141 amino
cids of the 142 amino acids that make up the VP1-
pecific region of MVMp was cloned, with a 6-residue
istidine tag at its carboxy-terminus, into a bacterial
xpression vector, pQE-60 (Qiagen, Chatsworth, CA),
hich allowed it to be expressed to high levels under the
ontrol of lac promoter/operator sequences. The VP1
rotein encoded by this plasmid, p(His)6-tag-VP1, is
ade up of an N-terminal 11-amino-acid exon (MVMp
ucleotides 2286–2316) spliced to a second exon start-
ng at nucleotide 2399 and extending to nucleotide 2790
n MVM, as shown in Fig. 1. Polymerase chain reaction
rimers were used to insert an NcoI site at the amino-
erminus of VP1 and a BglII site at the downstream end
f the VP1-specific region above, thus allowing it to be
nserted in-frame, at its C-terminus, with the histidine tag
equence provided by the vector.
Very few transformants were isolated when p(His)6-
ag-VP1 was transformed into bacterial hosts, such as
M109, that failed to repress fully expression of the
loned sequence. Six of these transformants examined
y DNA sequencing contained different single-point mu-
ations scattered throughout the VP1 sequence, five of
hich influenced the predicted coding sequence. Inter-
stingly, all attempts to recombine these plasmids to
btain wild-type transformants failed, suggesting that
ven low-level expression of the wild-type sequence
ight be toxic. The relief of such an extreme negative
ffect by single point mutations suggests that it is elic-
ted by the VP1-specific peptide through a particular
iological mechanism, which currently remains un-
nown. To circumvent this problem, plasmids were trans-
ormed into bacterial strain M15 containing pREP4, an F9
lasmid that expresses the lac i gene (Qiagen, Chats-
orth, CA). pREP4 can be maintained under constant
anamycin selection, ensuring tight down-regulation of
rotein expression from the lac promoter in the absence
f activator. Using this approach, transformants contain-
ng the wild-type VP1-specific sequence were obtained
ith close to normal frequency. The presence of a cor-
ect copy of the VP1-specific region in the final plasmid
as confirmed by DNA sequencing.
VP1-(His)6 peptide expression was induced by the
ddition of 2 mM isopropyl-b-D-thiogalactoside (Re-
earch Products International, Prospect, IL), and cells
ere harvested 4 h later. Since most of the induced
eptide was insoluble, bacterial pellets were extracted
ith guanidinium hydrochloride, and the peptide was
artially purified by chromatography on nickel–agarose
ccording to protocols supplied by the manufacturer
Qiagen). Fractions containing VP1-(His)6 were precipi-
ated with ethanol and further purified by electrophoresis
hrough SDS–PAGE gels. The VP1-specific peptide was oxcised and used to immunize a rabbit by a standard
rotocol employing Freund’s adjuvant.
nti-peptide antibody production
Three oligopeptides were synthesized to enable the
roduction of specific polyclonal antibodies for these
tudies. “MAPPA” is a 20mer peptide, NH2-A P P A K R A
R G W V P P G Y K Y L [C-COOH], that recapitulates the
equence of the 19 amino-terminal amino acids of MVMp
P1. “MSDGT” is a 25mer peptide with the sequence
H2-M S D G T S Q P D G G N A V H S A A R V E R A
[C-COOH], which corresponds to residues 1 through
4 of the VP2 sequence. An 18mer oligopeptide denoted
llopeptide represents the sequence between amino
cid residues 311 and 327 in the MVMp VP2 sequence,
amely, NH2-Q G S R H G T T Q M G V N W V S K
C-COOH]. This spans an allotropic determinant within
he MVMp coat, specifically comprising amino acids
317 and G321, which will switch the host range pheno-
ype of the virus from lymphotropic to fibrotropic when
oordinately substituted for A317 and E321 in the coat of
VMi (Ball-Goodrich and Tattersall, 1992).
In each case, an additional carboxy-terminal cysteine
esidue was added to each oligopeptide, to allow effi-
ient conjugation to keyhole limpet hemocyanin. This
tep was accomplished using a conjugation kit (Pierce
hemical Corp., Rockford, IL) as directed by the supplier.
ntibodies were raised in rabbits by repeated injection of
he conjugate at multiple sites according to an approved
rotocol employing Freund’s adjuvant.
ntibody purification
Sera directed against the MAPPA peptide showed
eactivity against MVM particles that could not be inhib-
ted by addition of the immunizing peptide. To overcome
his problem, the peptide was conjugated to Reacti-
el-6X (Pierce Chemical Corp.) according to instructions
rovided by the manufacturer, and the antibodies were
urified by affinity-chromatography (Harlow and Lane,
988).
eat treatment, immunoprecipitation, and enzyme
eactions
Purified virus particles are readily denatured by ex-
reme dilution into protein-free medium. To avoid such
ffects, viral particles were first diluted into 10 vol of
issue culture medium containing 10% fetal calf serum
nd incubated for 15 min at room temperature before
eing heated to the specified temperature for 3–10 min
s indicated.
For immunoprecipitation, 70 vol of buffer A (0.01 M
ris–HCl, pH 8.0, 0.15 M NaCl, 0.002 M EDTA) containing
% Nonidet-P40 was added, and samples were captured
n formalin-fixed Staphylococcus aureus (Boehringer
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180 COTMORE ET AL.annheim, Mannheim, Germany) as previously de-
cribed (Cotmore and Tattersall, 1986).
For digestion with P1 nuclease (Calbiochem–Novabio-
hem Corp., La Jolla, CA) heat-treated samples (in 10 vol
f medium plus 10% fetal calf serum) were incubated at
7°C for 20 min with 0.125 units of enzyme (1 ml at 0.25
g/ml, made up in 0.3 M sodium acetate, pH 5.2, 200 mM
nCl), and reactions were stopped with EDTA. Samples
ere incubated with proteinase K (50 mg/ml) in the pres-
nce of 0.5% SDS prior to electrophoresis through neu-
ral agarose gels.
For second-strand synthesis, heat-treated samples
ere incubated with 0.25 ml of Sequenase (U.S. Bio-
hemical, Cleveland, OH) in the presence of all four
nlabeled deoxynucleotides (250 mM), for 45 min at 37°C
sing conditions specified by the manufacturer. Reac-
ions were stopped and samples were proteolysed as
escribed for P1 nuclease, and samples were electro-
horesed through denaturing, alkaline agarose gels.
el electrophoresis
Unless specified to the contrary, proteins were ana-
yzed by electrophoresis through discontinuous poly-
crylamide gels (7.5% acrylamide, 0.2% bis-acrylamide)
n the presence of SDS according to the procedure of
aemmli (1970), and gels were incubated in 1 M salicylic
cid (adjusted to pH 7.5 with NaOH) prior to drying and
xposure to film. Gradient gels (4–20%) contained 0.1%
DS and were prepared with an acrylamide:bis-acryl-
mide ratio of 60:1.
Neutral or alkaline agarose gels were prepared ac-
ording to standard procedures (Maniatis et al., 1982).
amples for electrophoretic mobility shift assays (15 ml)
enerally contained buffer A (without detergent) and
ere incubated for 30 min at room temperature prior to
he addition of 1/10 vol of sample buffer (to give 0.3%
romphenol blue and xylene cyanol, 50 mM Tris–HCl, 20
M EDTA, 0.2% sarkosyl, 30% glycerol, pH 7.5) and elec-
rophoresis through 1% neutral agarose gels in Tris–
cetate buffer (40 mM Tris–acetate, 1 mM EDTA, pH 8.5).
n experiments where some samples were heat-treated,
ll samples were initially preincubated with 10% fetal
ovine serum at room temperature as described above.
amples (15 ml) to be digested with trypsin (2 mg) were
ncubated in 100 mM NaCl, 100 mM sodium acetate, 5
M DTT, pH 7.5, for 1 h at 37°C. After electrophoresis,
els were fixed in 7% trichloracetic acid, neutralized,
artially dehydrated by blotting on paper towels, infused
ith 1 M salicylic acid–NaOH, pH 7.5 (for 35S-labeled
amples), dried, and exposed to film. Quantitation of
ands was accomplished on a PhosphorImager SI using
mageQuaNT software (Molecular Dynamics, Sunnyvale,
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